The purpose of the trials is to involve patients in finding new and better treatments for mesothelioma diseases. Several clinical studies have different objectives, which may include the study of new drugs compare different ways of treating a disease or the study of various techniques for preventing cancer. Clinical trials are divided into three phases. Here, we show brief summaries of the goal of each phase of the trial.
The Phase I clinical studies are the first phase of clinical trial system. At this stage, the drugs have only been tested in the laboratory, but have had an effect on the destruction of cancer cells. These trials enroll only a limited number of participants and only made in limited centers specializing in the study of cancer. The objective of Phase I clinical studies is to find the maximum tolerated dose of the drug that causes no significant side effects, knowing the most common side effects if the drug continues to exhibit anticancer activity when administered to humans. If it is demonstrated that the drug has an effect on cancer using a safe dose, then the drug is examined in phase II clinical studies.
